Clinical Trials Details

A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (GALAXI)

Location: Carle - Digestive Health Center

Body site or condition: Inflammatory Bowel Disease – Crohn’s Disease

Department: Digestive Health

The purpose of this program is to evaluate the efficacy and safety of guselkumab in participants with Crohn's disease.

Apply Now

First Name:

Last Name:

Where may we contact you?:

When may we contact you?:

Phone Number:

Email:

I am at least 18 years of age

reCAPTCHA: